Product Information
INVEGA ER 9 MG TABLET is a brand product labeled by Janssen Pharmaceuticals Inc., priced at $18.6207 per EA under NDC 50458055201. Its NADAC has been published 652 times since Nov 28, 2013.
FDA first approved this application on Dec 19, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the paliperidone market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
9 mg/1
Manufacturer
Janssen Pharmaceuticals Inc.NDC
50458055201
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
PALIPERIDONEApproval Type
New Drug (NDA)
FDA Application
NDA021999FDA Approved
12/19/2006
TE Code
AB
On Market Since
12/19/2006
Pharmacological Classes
Price Statistics
The NADAC for INVEGA ER 9 MG TABLET has been published 652 times since Nov 28, 2013, and over the history we have for it it has declined 42.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $18.6207 per EA |
|---|---|
| All-time high | $59.3988 (Sep 29, 2021) |
| All-time low | $17.6782 (Apr 17, 2024) |
| 52-week high | $18.6531 |
| 52-week low | $18.1100 |
| Median price | $41.3367 |
| Average price | $37.5296 |
| Largest weekly change | -70.0% (Oct 6, 2021) |
| Weeks tracked | 652 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 95% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of INVEGA ER 9 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for INVEGA ER 9 MG TABLET, manufactured by Janssen Pharmaceuticals Inc., is $18.6207 per EA (NDC 50458055201), effective Aug 19, 2026.
How has the price of INVEGA ER 9 MG TABLET changed over time?
Over the history we have for it, the NADAC for INVEGA ER 9 MG TABLET has declined 42.3%. It has been tracked across 652 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for INVEGA ER 9 MG TABLET?
Since Nov 28, 2013, the NADAC for INVEGA ER 9 MG TABLET has ranged from a low of $17.6782 (Apr 17, 2024) to a high of $59.3988 (Sep 29, 2021), with a median of $41.3367 per EA.
Are there cheaper alternatives to INVEGA ER 9 MG TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PALIPERIDONE ER 9 MG TABLET, is $1.0186 per EA — about 95% below INVEGA ER 9 MG TABLET.
Who manufactures INVEGA ER 9 MG TABLET?
INVEGA ER 9 MG TABLET (NDC 50458055201) is labeled by Janssen Pharmaceuticals Inc., and CMS classifies it as a brand product.